The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 39%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (51 analysts) rates it buy, with a mean price target of $535. Insiders have been net sellers over the past quarter.
CrowdStrike
CRWD · a US exchange · USD · Market cap $186.6B · 10,698 employees
CrowdStrike Holdings, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-07-24
Screened 2026-07-24 · the tape above runs as of 22:40 UTC · 24 Jul · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
CrowdStrike holds its Accumulation at $183.28. The statistical read favours the buyers, held for 14 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the buyers, held for 14 days |
| Price at the screen | $183.28 |
| Valuation | N/A trailing · 117.30 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.24 |
Five Screens, Shown in Full
Does not pass. Accounts receivable
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 7.40% | Below 33% | Interest-bearing debt is just 7.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.69% | Below 33% | Cash held in interest-bearing accounts and securities is 0.7% of assets, under the one-third limit. | Pass |
| Receivables | 59.46% | Below 49% | Money owed to the company is 59.5% of assets, above the 49% limit. | Fail |
| Revenue purity | 4.05% | Below 5% | Only 4.1% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $114.63 fair value estimate, weak competitive moat, 25.60% revenue growth.
Fair value range in USD, drawn from the 2026-07-24 screen. The gold marker is the market price at the same screen. The price runs 37.5% above the base estimate.
Third-party analyst targets: 49 covering, consensus Buy. The average target sits +3% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-07-24 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCybersecurity darling priced far beyond reality
Picture every boardroom fretting over the next ransomware hit and reaching for the name that tops every shortlist. CrowdStrike sits there, selling cloud delivered protection through a subscription model that has delivered 26% revenue growth. Yet the shares trade at 130 times forward earnings while the business posts a negative profit margin and zero return on equity.
We pass for two clear reasons that have nothing to do with whether the product works. The price sits 44% above our fair value of 113.99, and the ethical screen flags a failure on accounts receivable. Weak moat and unprofitable operations complete the picture. Analyst enthusiasm and an 188 median target do not change those facts.
Valuation risk remains the obvious danger, with any slowdown in new subscriptions likely to expose the gap between price and underlying performance. The ethical issue adds a further layer that cannot be ignored. Analysis, not advice.
| Forward P/E | 117.3xexpensive even after accounting for its growth |
| EPS, trailing | -0.04 |
| EPS, forward | 1.56 |
| Revenue growth | +25.6%strong top-line growth |
| Profit margin | -0.6%currently unprofitable |
| Return on equity | -0.2%not currently earning a positive return on equity |
| FCF yield | 1.03% |
| Debt to equity | 0.18minimal debt: a conservative balance sheet |
| Current ratio | 1.53healthy short-term liquidity |
| Beta | 1.24moves a little more than the market |
| Short interest, float | 0.03% |
| 52-week range | 85.68 - 217.50 |
| Moat | WEAK |
| Market cap | $186.6B |
| Employees | 10,698 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCRWD trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Nvidia CEO Backs Open AI Models GuruFocus.com · 2d ago
- CrowdStrike (CRWD) Is a Trending Stock: Facts to Know Before Betting on It Zacks · 2d ago
- Here's What to Expect From CrowdStrike’s Next Earnings Report Barchart · 2d ago
- Cerebras Systems (CBRS) Teams Up With CrowdStrike To Push AI Cybersecurity Simply Wall St. · 3d ago
- Cerebras Scores With CrowdStrike Deal: What it Means for Investors Zacks · 3d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-29 | Kurtz George | Pres, CEO | Sale | 1,967 | $1,421,423 |
| 2026-05-28 | Kurtz George | Pres, CEO | Sale | 2,193 | $1,486,491 |
| 2026-05-27 | Kurtz George | Pres, CEO | Sale | 3,340 | $2,165,165 |
| 2026-05-19 | GANDHI SAMEER K. | Director | 5,429 | $3,412,930 | |
| 2026-05-19 | KURTZ GEORGE ROBERT | Chief Executive Officer | 4,840 | $2,978,615 | |
| 2026-05-19 | KURTZ GEORGE ROBERT | Chief Executive Officer | 160 | $101,018 | |
| 2026-05-15 | KURTZ GEORGE ROBERT | Chief Executive Officer | 2,500 | $1,468,786 | |
| 2026-05-14 | GANDHI SAMEER K. | Director | 10,000 | $5,800,313 | |
| 2026-05-14 | KURTZ GEORGE ROBERT | Chief Executive Officer | 3,072 | $1,708,607 | |
| 2026-05-14 | KURTZ GEORGE ROBERT | Chief Executive Officer | 1,928 | $1,115,594 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-04-24 | Ro Khanna | Democrat | Purchase | 1K–15K |
| 2026-04-13 | Ro Khanna | Democrat | Sale | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $542.26 | +19.6% | · | $1,196 | +19.6% |
| 2 months | $379.02 | +71.1% | · | $1,711 | +71.1% |
| 3 months | $441.54 | +46.9% | · | $1,469 | +46.9% |
| 6 months | $517.65 | +25.3% | · | $1,253 | +25.3% |
| 1 year | $467.65 | +38.7% | · | $1,387 | +38.7% |
| 2 years | $374.57 | +73.1% | · | $1,731 | +73.1% |
| 3 years | $149.53 | +333.7% | · | $4,337 | +333.7% |
| 5 years | $231.27 | +180.4% | · | $2,804 | +180.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CRWD does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.